Physician profile

Bahaeddin Shabaneh

Cardiovascular Disease · Webster, TX

NPI 1659397099

$21,397.60

in general payments reported to CMS, 2019-2025

57 companies · $3,252 in 2025

The $3,252 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,812.36
Long Term Medical Supply Or Device Loan$281.66
Education$176.25

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $3,561.96 2019-2025 Cardiomems, Portico, Diamondback Peripheral
Bard Peripheral Vascular, INC. $3,438.20 2019-2020
Boston Scientific Corporation $2,247.63 2019-2025 Emblem Mri S-Icd, Watchman Access System, Ekosonic
Edwards Lifesciences Corporation $1,475.33 2019-2025 Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Novartis Pharmaceuticals Corporation $1,035.97 2019-2025
Medtronic, INC. $956.94 2021-2025 Corevalve Evolut R, Venaseal
Cardiovascular Systems INC. $919.70 2019
Merck Sharp & Dohme LLC $587.46 2021-2025 Verquvo, Capvaxive
Impulse Dynamics (USA) INC. $583.79 2022-2024 Optimizer, Optimizer
Janssen Pharmaceuticals, INC $583.20 2019-2024 Xarelto
Abiomed $573.38 2019-2025 Impella
Astrazeneca Pharmaceuticals LP $492.40 2019-2025 Farxiga, Andexxa, Wainua
Medtronic Vascular, INC. $382.85 2020
Amgen INC. $376.23 2019-2025 Repatha, Repatha
Actelion Pharmaceuticals US, INC. $322.17 2024-2025 Uptravi, Opsumit, Opsynvi
Show all 57 companies
CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $296.51 2019-2025 Jardiance
Esperion Therapeutics, INC. $293.73 2020-2025 Nexletol
Pfizer INC. $264.51 2019-2025
Novo Nordisk INC $262.36 2024-2025 Wegovy, Ozempic
E.R. Squibb & Sons, L.L.C. $246.76 2021-2025 Camzyos, Eliquis
Amarin Pharma, INC. $217.97 2019-2022
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $194.96 2019-2025 Lifevest
Scpharmaceuticals INC. $187.39 2025
Heartflow, INC. $185.07 2025
Tactile Systems Technology INC $167.02 2019-2024 Flexitouch Plus, Entre Plus
Inari Medical, INC. $106.94 2022-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Angiodynamics, INC. $99.58 2021-2024 Alphavac
Gilead Sciences, INC. $86.76 2020
Itamar Medical INC $82.36 2022
Shockwave Medical, INC $81.60 2021
Lexicon Pharmaceuticals, INC. $78.98 2023-2024 Inpefa
Zoll Circulation INC $75.97 2020-2021
Chiesi USA, INC. $74.58 2021-2022
Sanofi-Aventis U.S. LLC $73.49 2019-2023
Abbvie INC. $73.42 2021-2022
Cardiva Medical, INC. $63.98 2024 Savvywire
Cvrx, INC. $59.23 2023-2024 Barostim Neo System
Viiv Healthcare Company $57.71 2020
Kestra Medical Technology Services, INC. $49.66 2025 Assure Wcd
Arbor Pharmaceuticals, INC. $49.49 2019-2022
Irhythm Technologies, INC. $47.72 2023 Zio Xt Patch
Bayer Healthcare Pharmaceuticals INC. $42.60 2021-2022
Lundbeck LLC $39.26 2020-2021
Allergan, INC. $38.06 2020
Lilly USA, LLC $36.69 2025 Zepbound, Mounjaro
Regeneron Healthcare Solutions, INC. $35.99 2019
Avinger INC. $34.21 2021
Imperative Care, INC $22.15 2025 Symphony Catheter
Sensible Medical Innovations INC $16.77 2025 Reds System
Janssen Biotech, INC. $16.51 2019
Kiniksa Pharmaceuticals, LTD. $16.41 2023 Arcalyst
Azurity Pharmaceuticals, INC. $15.50 2024 Edarbyclor
Teleflex LLC $14.76 2020
Shionogi INC $14.39 2021
Cook Medical LLC $13.62 2021
Emd Serono, INC. $12.99 2019
Vyera Pharmaceuticals, LLC $12.73 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Bahaeddin Shabaneh

$21,397.60

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $3,252 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/166389/bahaeddin-shabaneh

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.